Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR

Choi J, JongYeob Choi, Jo M, MinWha Jo, Eunyoung Lee, Lee E, Dong‐Yun Lee, Lee DY, Dong-Yun Lee, DooSeok Choi, Choi D
Fertility and sterility · 2015 · vol. 104(3) , pp. 655–664.e1 · doi:10.1016/j.fertnstert.2015.05.020 · PMID:26051103 · W2116031379
article OA: bronze CC0 ⤵ 53 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-16 ⓘ

Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR signaling pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo elucidate the therapeutic mechanisms of progestin and the effects of progesterone and progestin (dienogest) on autophagy induction and regulation in endometriotic cells, specifically the effects of progesterone and dienogest on the phosphoinositide-3/protein kinase B (PI3K-AKT) and mitogen-activated protein kinase kinases 1 and 2 (MEK1/2)/extracellular-signal-regulated kinase 1/2 (ERK1/2) pathways, which activate mammalian target of rapamycin (mTOR), a major negative regulator of autophagy.DesignIn vitro study using human endometriotic cyst stromal cells (ECSCs).SettingUniversity medical center.Patient(s)Fifteen patients with ovarian endometrioma.Intervention(s)ECSCs treated with progesterone or dienogest.Main outcome measure(s)Autophagy as measured by the expression of the microtubule-associated protein light chain 3-II (LC3-II) and autophagosome formation, and levels of AKT, ERK1/2, and mTOR activity to quantify the phosphorylation of AKT, ERK1/2, and S6K (the downstream target of mTOR).Result(s)Progesterone treatment had not statistically significant effect on LC3-II expression, autophagosome formation, or phosphorylation of AKT, ERK1/2, or S6K in estrogen-treated ECSCs. However, dienogest treatment up-regulated LC3-II expression and stimulated autophagosome formation. These effects were accompanied by decreased activation of AKT, ERK1/2, and S6K. Furthermore, incubation of ECSCs with AKT and ERK1/2 inhibitors, which mimicked dienogest-mediated inhibition of AKT and ERK1/2 activity, suppressed S6K activity, followed by an increase in LC3-II expression. In addition, cotreatment with dienogest and 3-methyladenine (autophagy inhibitor) decreased the levels of apoptosis of ECSCs compared with the single treatment with dienogest.Conclusion(s)Our results suggest that dienogest treatment of endometriotic cells suppresses AKT and ERK1/2 activity, thereby in turn inhibiting mTOR, inducing autophagy, and promoting apoptosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Autophagy Endometriosis Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Nandrolone Ovarian Cysts Proto-Oncogene Proteins c-akt Stromal Cells TOR Serine-Threonine Kinases Apoptosis Apoptosis Autophagy Cells, Cultured Endometriosis Endometriosis Enzyme Activation Female Humans Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-25T06:15:30.875455+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:52.213533+00:00
License: CC0 · commercial use OK